Your browser doesn't support javascript.
loading
The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.
Pastor-Idoate, Salvador; Rodriguez-Hernández, Irene; Rojas, Jimena; Fernández, Itziar; García-Gutierrez, María Teresa; Ruiz-Moreno, Jose María; Rocha-Sousa, Amandio; Ramkissoon, Yashin; Harsum, Steven; MacLaren, Robert E; Charteris, David; van Meurs, Jan; González-Sarmiento, Rogelio; Pastor, Jose Carlos.
Afiliação
  • Pastor-Idoate S; Department of Ophthalmology, University Hospital of Valladolid, Valladolid, Spain; Molecular Medicine Unit, Department of Medicine, University of Salamanca, Salamanca, Spain; Instituto Universitario de Oftalmobiología Aplicada (IOBA), Retina Group, University of Valladolid, Valladolid, Spain.
  • Rodriguez-Hernández I; Molecular Medicine Unit, Department of Medicine, University of Salamanca, Salamanca, Spain.
  • Rojas J; Instituto Universitario de Oftalmobiología Aplicada (IOBA), Retina Group, University of Valladolid, Valladolid, Spain.
  • Fernández I; Instituto Universitario de Oftalmobiología Aplicada (IOBA), Retina Group, University of Valladolid, Valladolid, Spain.
  • García-Gutierrez MT; Instituto Universitario de Oftalmobiología Aplicada (IOBA), Retina Group, University of Valladolid, Valladolid, Spain.
  • Ruiz-Moreno JM; University of Castilla la Mancha, Vissum, Albacete, Spain.
  • Rocha-Sousa A; Department of Sense Organs, Faculty of Medicine, University of Porto, Hospital San João, Porto, Portugal.
  • Ramkissoon Y; Moorfields Eye Hospital, National Institute Health Research (NIHR), Biomedical Research Centre, London, United Kingdom.
  • Harsum S; Moorfields Eye Hospital, National Institute Health Research (NIHR), Biomedical Research Centre, London, United Kingdom.
  • MacLaren RE; Moorfields Eye Hospital, National Institute Health Research (NIHR), Biomedical Research Centre, London, United Kingdom; Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom.
  • Charteris D; Moorfields Eye Hospital, National Institute Health Research (NIHR), Biomedical Research Centre, London, United Kingdom.
  • van Meurs J; Rotterdam Eye Hospital, Erasmus University, Rotterdam, The Netherlands.
  • González-Sarmiento R; Molecular Medicine Unit, Department of Medicine, University of Salamanca, Salamanca, Spain; Instituto de Biología Molecular y Celular del Cancer (IBMCC), University of Salamanca Consejo Superior de Investigaciones Científicas (CSIC), Salamanca, Spain.
  • Pastor JC; Department of Ophthalmology, University Hospital of Valladolid, Valladolid, Spain; Instituto Universitario de Oftalmobiología Aplicada (IOBA), Retina Group, University of Valladolid, Valladolid, Spain. Electronic address: pastor@ioba.med.uva.es.
Ophthalmology ; 120(3): 623-628, 2013 Mar.
Article em En | MEDLINE | ID: mdl-23207172
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Códon / Proteína Supressora de Tumor p53 / Vitreorretinopatia Proliferativa / Polimorfismo de Nucleotídeo Único Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Códon / Proteína Supressora de Tumor p53 / Vitreorretinopatia Proliferativa / Polimorfismo de Nucleotídeo Único Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Espanha